Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,733 | -2,340 | -14,260 | -10,540 | -6,549 |
| Depreciation Amortization | 3 | 1 | 3 | 1 | 1 |
| Accounts receivable | N/A | -250 | N/A | -213 | N/A |
| Other Working Capital | -115 | -1,262 | 1,250 | 692 | -133 |
| Other Operating Activity | 120 | 325 | -353 | 6 | -333 |
| Operating Cash Flow | $-5,725 | $-3,526 | $-13,360 | $-10,054 | $-7,014 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | N/A | -10 | N/A | N/A |
| Investing Cash Flow | $-4 | $N/A | $-10 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -138 | -88 | -790 | -524 | -260 |
| Common Stock Issued | 10,439 | 4,941 | 14,401 | 14,401 | 1,775 |
| Common Stock Repurchased | N/A | N/A | 2,274 | N/A | N/A |
| Other Financing Activity | -552 | -413 | -627 | -333 | -16 |
| Financing Cash Flow | $9,749 | $4,440 | $15,258 | $13,544 | $1,499 |
| Beginning Cash Position | 12,409 | 12,409 | 10,521 | 10,521 | 10,521 |
| End Cash Position | 16,429 | 13,323 | 12,409 | 14,011 | 5,006 |
| Net Cash Flow | $4,020 | $914 | $1,888 | $3,490 | $-5,515 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,725 | -3,526 | -13,360 | -10,054 | -7,014 |
| Capital Expenditure | -4 | N/A | -10 | N/A | N/A |
| Free Cash Flow | -5,729 | -3,526 | -13,370 | -10,054 | -7,014 |